GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 701 filers reported holding GLAXOSMITHKLINE PLC in Q3 2014. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $573,000 | -69.1% | 13,152 | -68.7% | 0.06% | -69.8% |
| Q4 2021 | $1,854,000 | +21.4% | 42,048 | +5.2% | 0.20% | +10.2% |
| Q3 2021 | $1,527,000 | -49.4% | 39,952 | -49.9% | 0.19% | -2.6% |
| Q2 2021 | $3,017,000 | +117.7% | 79,804 | +105.5% | 0.19% | +4.4% |
| Q1 2021 | $1,386,000 | +2.1% | 38,840 | +5.2% | 0.18% | -11.2% |
| Q4 2020 | $1,358,000 | +9.5% | 36,910 | +12.1% | 0.21% | -7.2% |
| Q3 2020 | $1,240,000 | -8.9% | 32,935 | -1.3% | 0.22% | -11.9% |
| Q2 2020 | $1,361,000 | +6.1% | 33,375 | -1.5% | 0.25% | -7.0% |
| Q1 2020 | $1,283,000 | -11.8% | 33,869 | +9.5% | 0.27% | +14.3% |
| Q4 2019 | $1,454,000 | +14.8% | 30,934 | +4.2% | 0.24% | +8.2% |
| Q3 2019 | $1,267,000 | +9.3% | 29,687 | +2.5% | 0.22% | +6.3% |
| Q2 2019 | $1,159,000 | +2.9% | 28,967 | +7.5% | 0.21% | -1.4% |
| Q1 2019 | $1,126,000 | +13.6% | 26,953 | +4.0% | 0.21% | -9.5% |
| Q4 2018 | $991,000 | +1.8% | 25,926 | +7.0% | 0.23% | +17.9% |
| Q3 2018 | $973,000 | -4.2% | 24,226 | -3.9% | 0.20% | -11.3% |
| Q2 2018 | $1,016,000 | +11.0% | 25,204 | +7.7% | 0.22% | +4.7% |
| Q1 2018 | $915,000 | +14.4% | 23,409 | +3.7% | 0.21% | +15.3% |
| Q4 2017 | $800,000 | -10.4% | 22,565 | +2.6% | 0.18% | -16.8% |
| Q3 2017 | $893,000 | -0.9% | 21,992 | +5.3% | 0.22% | -6.8% |
| Q2 2017 | $901,000 | +21.4% | 20,889 | +18.7% | 0.24% | +16.8% |
| Q1 2017 | $742,000 | +14.2% | 17,599 | +4.3% | 0.20% | +4.7% |
| Q4 2016 | $650,000 | -9.8% | 16,874 | +0.9% | 0.19% | -14.6% |
| Q3 2016 | $721,000 | +20.2% | 16,721 | +20.7% | 0.23% | +10.8% |
| Q2 2016 | $600,000 | +14.3% | 13,855 | +7.0% | 0.20% | +10.3% |
| Q1 2016 | $525,000 | +0.2% | 12,952 | -0.2% | 0.18% | -3.1% |
| Q4 2015 | $524,000 | -3.1% | 12,980 | -7.8% | 0.19% | -12.4% |
| Q3 2015 | $541,000 | -3.6% | 14,075 | +4.4% | 0.22% | +0.9% |
| Q2 2015 | $561,000 | +1.3% | 13,481 | +12.3% | 0.22% | +0.9% |
| Q1 2015 | $554,000 | +24.2% | 12,001 | +15.1% | 0.21% | +16.9% |
| Q4 2014 | $446,000 | +18.0% | 10,425 | +26.9% | 0.18% | +9.6% |
| Q3 2014 | $378,000 | +44.8% | 8,215 | +68.5% | 0.17% | +41.5% |
| Q2 2014 | $261,000 | – | 4,875 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |